Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)

SHE:301501 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,788	1,562	1,396	1,054	696.15	415.09
Other Revenue	32.16	32.16	29.51	33.89	22.75	9.36
Revenue	1,820	1,594	1,425	1,088	718.9	424.44
Revenue Growth (YoY)	27.71%	11.87%	30.95%	51.38%	69.37%	-22.03%
Cost of Revenue	1,378	1,178	1,023	786.93	524.89	286.38
Gross Profit	441.85	416.43	401.63	301.34	194.01	138.06
Selling, General & Admin	124.86	100.28	93.46	70.71	51.85	72.56
Research & Development	54.64	53.31	44.21	35.91	32.15	19.62
Other Operating Expenses	6.49	6.93	6.04	4.29	4.23	3.24
Operating Expenses	186.92	161.4	146.94	113.04	88.65	95.25
Operating Income	254.94	255.03	254.69	188.3	105.36	42.81
Interest Expense	-9.76	-10.03	-5.31	-4.41	-2.62	-2.09
Interest & Investment Income	4.71	2.35	3.01	1.66	1.03	2.05
Earnings From Equity Investments	-0	-0	-	-	-	-
Currency Exchange Gain (Loss)	-5.91	-5.91	3.65	7.03	-2.4	-3.87
Other Non Operating Income (Expenses)	47.9	11.38	-0.39	-0.33	-0.26	-1.24
EBT Excluding Unusual Items	291.88	252.82	255.65	192.25	101.11	37.66
Gain (Loss) on Sale of Investments	2.17	-	-2.14	-5.5	-11.29	-8.1
Gain (Loss) on Sale of Assets	0.31	0.88	-0.3	0.24	0.05	-
Asset Writedown	-1.89	-0.51	-2.41	-1.17	-0.01	-0.25
Other Unusual Items	8.04	8.04	7.2	6.08	4.08	6.15
Pretax Income	300.52	261.24	258.01	191.91	93.94	35.45
Income Tax Expense	45.84	34.43	36.56	25.95	12.86	10.58
Earnings From Continuing Operations	254.68	226.81	221.46	165.95	81.08	24.88
Minority Interest in Earnings	-11.91	-6.92	-7.59	-3.19	-0.92	1.21
Net Income	242.77	219.89	213.86	162.77	80.16	26.09
Net Income to Common	242.77	219.89	213.86	162.77	80.16	26.09
Net Income Growth	13.52%	2.82%	31.39%	103.04%	207.30%	-62.87%
Shares Outstanding (Basic)	132	111	111	111	105	-
Shares Outstanding (Diluted)	132	111	111	111	105	-
Shares Change (YoY)	19.59%	0.31%	-0.04%	5.81%	-	-
EPS (Basic)	1.83	1.98	1.93	1.47	0.77	-
EPS (Diluted)	1.83	1.98	1.93	1.47	0.77	-
EPS Growth	-5.08%	2.50%	31.45%	91.90%	-	-
Free Cash Flow	-103.79	-78.83	-110.86	2.58	9.75	-27.11
Free Cash Flow Per Share	-0.78	-0.71	-1.00	0.02	0.09	-
Dividend Per Share	0.345	0.345	-	-	-	-
Gross Margin	24.28%	26.12%	28.18%	27.69%	26.99%	32.53%
Operating Margin	14.01%	16.00%	17.87%	17.30%	14.66%	10.09%
Profit Margin	13.34%	13.79%	15.01%	14.96%	11.15%	6.15%
Free Cash Flow Margin	-5.70%	-4.95%	-7.78%	0.24%	1.36%	-6.39%
EBITDA	340.96	322.51	297.44	221.74	129.15	62.83
EBITDA Margin	18.73%	20.23%	20.87%	20.38%	17.96%	14.80%
D&A For EBITDA	86.02	67.48	42.75	33.43	23.79	20.02
EBIT	254.94	255.03	254.69	188.3	105.36	42.81
EBIT Margin	14.01%	16.00%	17.87%	17.30%	14.66%	10.09%
Effective Tax Rate	15.25%	13.18%	14.17%	13.52%	13.69%	29.83%
Revenue as Reported	1,820	1,594	1,425	1,088	718.9	424.44
Advertising Expenses	-	-	2	0.55	1.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.